[1] |
Cruz-Jentoft AJ, Sayer AA. Sarcopenia[J]. Lancet, 2019,393(10191):2636-2646.
doi: 10.1016/S0140-6736(19)31138-9
pmid: 31171417
|
[2] |
Terracciano C, Celi M, Lecce D, et al. Differential features of muscle fiber atrophy in osteoporosis and osteoarthritis[J]. Osteoporos Int, 2013,24(3):1095-1100.
doi: 10.1007/s00198-012-1990-1
pmid: 22535191
|
[3] |
Pinedo-Villanueva R, Westbury LD, Syddall HE, et al. Health care costs associated with muscle weakness:a UK population-based estimate[J]. Calcif Tissue Int, 2019,104(2):137-144.
doi: 10.1007/s00223-018-0478-1
pmid: 30244338
|
[4] |
李敏, 宋瑰琦, 任海燕, 等. Ishii评分在社区老年人肌少症筛查中的应用[J]. 中国护理管理, 2018,18(8):1034-1038.
|
|
Li M, Song GQ, Ren HY, et al. The application of Ishii’s scores in the screening for sarcopenia in community elderly[J]. Chin Nurs Manag, 2018,18(8):1034-1038.
|
[5] |
Li R, Hu X, Tan L, et al. Screening for sarcopenia with a self-reported cartoon questionnaire:combining SARC-F with finger-ring test[J]. J Nutr Heal Aging, 2020,24(10):1100-1106.
|
[6] |
Tanaka T, Takahashi K, Akishita M, et al. “Yubi-wakka”(finger-ring)test:a practical self-screening method for sarcopenia,and a predictor of disability and mortality among Japanese community-dwelling older adults[J]. Geriatr Gerontol Int, 2018,18(2):224-232.
doi: 10.1111/ggi.13163
pmid: 28898523
|
[7] |
Fujii H, Kodani E, Kaneko T, et al. “yubi-wakka”(finger-ring)test:a tool to detect prefrailty in elderly populations,a pilot study[J]. J Clin Med Res, 2019,11(9):623-628.
doi: 10.14740/jocmr3917
pmid: 31523335
|
[8] |
Hiraoka A, Izumoto H, Ueki H, et al. Easy surveillance of muscle volume decline in chronic liver disease patients using finger-circle(yubi-wakka)test[J]. J Cachexia Sarcopenia Muscle, 2019,10(2):347-354.
doi: 10.1002/jcsm.12392
pmid: 30793533
|
[9] |
Chen LK, Woo J, Assantachai P, et al. Asian working group for sarcopenia:2019 consensus update on sarcopenia diagnosis and treatment[J]. J Am Med Dir Assoc, 2020,21(3):300-307.
doi: 10.1016/j.jamda.2019.12.012
pmid: 32033882
|
[10] |
黄悦勤. 临床流行病学[M]. 北京: 人民卫生出版社, 2002: 88-97.
|
|
Huang YQ. Clinical epidemiology[M]. Beijing: People’s Medical Publishing House, 2002: 88-97.
|
[11] |
宋世明, 杜红珍, 李增宁. 恶性肿瘤患者低相位角与营养风险和住院时间相关性研究[C]//第十届全国中西医结合营养学术会议论文集. 成都, 2019: 461-471.
|
[12] |
劳期迎, 曹殿青. 生物电阻抗测量技术临床应用与研究进展[J]. 中国处方药, 2019,17(2):29-31.
|
|
Lao QY, Cao DQ. Clinical application and research progress of bioelectrical impedance measurement technology[J]. J China Prescr Drug, 2019,17(2):29-31.
|
[13] |
闫岩, 华琳, 张建. 对诊断一致性Kappa系数及评价指标的探讨[J]. 中国卫生统计, 2007,24(3):313-315.
|
|
Yan Y, Hua L, Zhang J. Discussion on Kappa coefficient and evaluation index of diagnostic consistency[J]. Chin J Heal Stat, 2007,24(3):313-315.
|
[14] |
Yang M, Lu J, Jiang J, et al. Comparison of four sarcopenia screening tools in nursing home residents[J]. Aging Clin Exp Res, 2019,31(10):1481-1489.
doi: 10.1007/s40520-018-1083-x
pmid: 30539542
|
[15] |
Ishida Y, Maeda K, Nonogaki T, et al. SARC-F as a screening tool for sarcopenia and possible sarcopenia proposed by AWGS 2019 in hospitalized older adults[J]. J Nutr Heal Aging, 2020(1):1-8.
|
[16] |
Uemura K, Makizako H, Lee S, et al. The impact of sarcopenia on incident homebound status among community-dwelling older adults:a prospective cohort study[J]. Maturitas, 2018,113:26-31.
doi: 10.1016/j.maturitas.2018.03.007
pmid: 29903645
|
[17] |
Akishita M, Kozaki K, Iijima K, et al. Chapter 1 Definitions and diagnosis of sarcopenia[J]. Geriatr Gerontol Int, 2018,18(Suppl 1):7-12.
doi: 10.1111/ggi.2018.18.issue-S1
|
[18] |
Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia:European consensus on definition and diagnosis:report of the European working group on sarcopenia in older people[J]. Age Ageing, 2010,39(4):412-423.
doi: 10.1093/ageing/afq034
pmid: 20392703
|